Table I.
UCA1 expression | ||||
---|---|---|---|---|
Variables | Cases (n=66) | Low (n=32) | High (n=34) | P-value |
Age (years) | 0.810 | |||
<55 | 30 | 14 | 16 | |
≥55 | 36 | 18 | 18 | |
Sex | 0.460 | |||
Male | 35 | 15 | 20 | |
Female | 31 | 17 | 14 | |
Tumor focality | 0.477 | |||
Solitary | 57 | 29 | 28 | |
Multiple | 9 | 3 | 6 | |
Histologic grade | 0.171 | |||
Well-moderate | 48 | 26 | 22 | |
Poor | 18 | 6 | 12 | |
Lymph node metastasis | 0.034 | |||
Present | 14 | 3 | 11 | |
Absent | 52 | 29 | 23 | |
Vascular invasion | 0.083 | |||
Present | 26 | 9 | 17 | |
Absent | 40 | 23 | 17 | |
HBV infection | 0.477 | |||
Present | 9 | 3 | 6 | |
Absent | 57 | 29 | 28 | |
Clinical T-stage | 0.027 | |||
T1/T2 | 38 | 23 | 15 | |
T3/T4 | 28 | 9 | 19 |
UCA1, urothelial carcinoma-associated 1.